Changes in body composition during therapy with SGLT2 inhibitors in patients with chronic kidney disease
- Conditions
- N18Chronic kidney disease
- Registration Number
- DRKS00028560
- Lead Sponsor
- niversitätsklinikum Tübingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Chronic kidney disease, initiation SGLT2 inhibitor for clinical indication
Exclusion Criteria
No informed consent.
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in volume status (measured by bioimpedance spectroscopy) at clinical control points during the observation period
- Secondary Outcome Measures
Name Time Method Change of blood pressure, body weight, laboratory parameters at clinical control points during the observation period